Ollie

Market position

Ollie is described in trade coverage as a strong leader in the fresh, human-grade dog food category, backed by investors that supported national cold-chain build-out. A secondary source characterizes it as a digital-first leader in fresh pet food competing with The Farmer's Dog, Hero and Open Farm within a growing fresh-frozen segment of the US pet food market.

Ollie positions itself on human-grade ingredient quality, ingredient transparency and traceability (sourcing and testing each ingredient and tracing batches), recipes formulated with veterinary nutritionists and chefs rather than heavy supplement use, and a proprietary algorithm/profile that personalizes formulas and caloric recommendations per dog. Personalized health tracking and AI-powered health screenings, strengthened by the DIG Labs acquisition, are presented as a further differentiator versus food-only competitors.

Technology

A proprietary algorithm and onboarding 'Ollie Profile' translate a dog's age, size, breed, body composition, activity level and allergies into a customized formula and caloric plan. The company maintains ingredient traceability from sourcing through batch-level tracking. Health check-ins and, per secondary sources, an app-based AI screening tool that analyzes stool imagery and activity data extend the product into diagnostics; this capability was reinforced by the acquisition of AI diagnostics company DIG Labs. Other cited technology includes a gently-cooked production process, proprietary portioning scoop and single-serve containers, and patented freshness-preserving packaging.

Go-to-market

Primarily direct-to-consumer online, with a quiz-based onboarding flow, first-box discount promotions and subscription retention. A secondary source describes a shift from paid social advertising toward influencer partnerships and organic referrals, plus an omnichannel move into retail via Petco refrigerated placements. Customer support is offered by email, phone, live chat and SMS through a 'Canine Care Center.'

US dog owners seeking fresh, human-grade alternatives to processed kibble, marketed to 'pet parents' who prioritize ingredient quality, transparency and measurable health outcomes for their dogs.

Geography

Headquartered in New York and serving the United States; the acquirer Agrolimen stated Ollie will continue to be headquartered in the US. A secondary source describes national cold-chain infrastructure, regional distribution centers established in late 2023, and retail distribution through Petco stores.

History

Public sources place Ollie's launch in 2016 in New York City as a direct-to-consumer subscription for fresh, human-grade dog meals, following an initial bootstrapping period spent solving cold-chain and shipping issues. A $4.4 million seed round co-led by Primary Venture Partners and Lerer Hippeau (with Canaan and WME participating) was followed by a $12.6 million Series A led by Canaan Partners in August 2017, at which point total funding stood at $17 million. A secondary source describes a $39 million Series B in 2020 led by Sycamore Partners and Tiger Global, growth to more than 50 employees by 2018, delivery of over 100 million meals by 2021, Petco placement in 800-plus stores by 2022, a 2023 packaging patent and regional distribution restructuring, an app-based AI health screening tool in 2023, and estimated annual revenue above $200 million by year-end 2024; these figures come from a single unverified secondary compilation and conflict on some points with other sources. In 2024 Ollie acquired DIG Labs, an AI pet-health diagnostics company. On February 6, 2026, Agrolimen announced its acquisition of Ollie.

Risks & controversies

Public sources note COVID-era supply chain disruption in 2021 that forced temporary price increases and logistics bottlenecks. Sourcing risk exists in this profile: several growth, revenue and milestone figures derive from a single secondary content-marketing site whose claims (including a 2016 founding date and a vet-founded characterization) are not independently corroborated and conflict with other records. A separate New York company also named Ollie operates in co-living real estate and is unrelated.